
Deirdre Renee Claytor
Supervisory Patent Examiner (ID: 19287, Phone: (571)272-8394 , Office: P/1651 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1627, 1651, 1691 |
| Total Applications | 768 |
| Issued Applications | 255 |
| Pending Applications | 49 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6178209
[patent_doc_number] => 20110178179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => '1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS'
[patent_app_type] => utility
[patent_app_number] => 12/998033
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11299
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998033 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS | Sep 1, 2009 | Abandoned |
Array
(
[id] => 5373635
[patent_doc_number] => 20090311196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'PHARMACEUTICAL AEROSOL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/547534
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5861
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547534
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547534 | Pharmaceutical aerosol composition | Aug 25, 2009 | Issued |
Array
(
[id] => 6548285
[patent_doc_number] => 20100222376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'CHELERYTHRINE, ANALOGS THEREOF AND THEIR USE IN THE TREATMENT OF BIPOLAR DISORDER AND OTHER COGNITIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/546737
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7150
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222376.pdf
[firstpage_image] =>[orig_patent_app_number] => 12546737
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/546737 | CHELERYTHRINE, ANALOGS THEREOF AND THEIR USE IN THE TREATMENT OF BIPOLAR DISORDER AND OTHER COGNITIVE DISORDERS | Aug 24, 2009 | Abandoned |
Array
(
[id] => 6048603
[patent_doc_number] => 20110207718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/057628
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32596
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207718.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057628
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057628 | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS | Aug 5, 2009 | Abandoned |
Array
(
[id] => 6636663
[patent_doc_number] => 20100035845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'TIGECYCLINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/535957
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7060
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12535957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/535957 | TIGECYCLINE FORMULATIONS | Aug 4, 2009 | Abandoned |
Array
(
[id] => 6258000
[patent_doc_number] => 20100029771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'TREATMENT OF ADDICTIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/533608
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6106
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029771.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533608 | TREATMENT OF ADDICTIVE DISORDERS | Jul 30, 2009 | Abandoned |
Array
(
[id] => 8352077
[patent_doc_number] => 08247406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Composition and method for treatment of MRSA'
[patent_app_type] => utility
[patent_app_number] => 12/512295
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512295
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/512295 | Composition and method for treatment of MRSA | Jul 29, 2009 | Issued |
Array
(
[id] => 7540425
[patent_doc_number] => 08058268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Neuroprotective agents for the prevention and treatment of neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 12/462182
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12325
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462182 | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases | Jul 28, 2009 | Issued |
Array
(
[id] => 7682163
[patent_doc_number] => 20100022645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'PKC-Activating Compounds for the Treatment of Neurodegenerative Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/510681
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11274
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510681 | PKC-activating compounds for the treatment of neurodegenerative diseases | Jul 27, 2009 | Issued |
Array
(
[id] => 8555263
[patent_doc_number] => 08329734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Topical therapy for migraine'
[patent_app_type] => utility
[patent_app_number] => 12/460966
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10413
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12460966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460966 | Topical therapy for migraine | Jul 26, 2009 | Issued |
Array
(
[id] => 6257481
[patent_doc_number] => 20100029661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Anesthetic compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/460954
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3349
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460954
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460954 | Anesthetic compositions and methods of use | Jul 26, 2009 | Issued |
Array
(
[id] => 8555288
[patent_doc_number] => 08329760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 12/505421
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7944
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12505421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505421 | Pharmaceutical composition | Jul 16, 2009 | Issued |
Array
(
[id] => 5465705
[patent_doc_number] => 20090325905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/492932
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 35575
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492932 | Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds | Jun 25, 2009 | Issued |
Array
(
[id] => 9503634
[patent_doc_number] => 08741949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue'
[patent_app_type] => utility
[patent_app_number] => 13/001422
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7267
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001422
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001422 | Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue | Jun 24, 2009 | Issued |
Array
(
[id] => 6039551
[patent_doc_number] => 20110092600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/737283
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8992
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092600.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737283 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES | Jun 24, 2009 | Abandoned |
Array
(
[id] => 5374868
[patent_doc_number] => 20090312429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders'
[patent_app_type] => utility
[patent_app_number] => 12/457754
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3700
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457754 | Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6628309
[patent_doc_number] => 20100004210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'METHOD AND SUBSTANCES FOR TREATING T-CELL MEDIATED AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/474184
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6992
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004210.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474184
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474184 | Method and substances for treating T-cell mediated autoimmune diseases | May 27, 2009 | Issued |
Array
(
[id] => 7490482
[patent_doc_number] => 20110237597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHOD OF TREATING PERIPHERAL NERVE SENSORY LOSS USING COMPOUNDS HAVING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/993457
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15504
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237597.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993457 | METHOD OF TREATING PERIPHERAL NERVE SENSORY LOSS USING COMPOUNDS HAVING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY | May 14, 2009 | Abandoned |
Array
(
[id] => 5386319
[patent_doc_number] => 20090227564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'DRUG FOR PREVENTION AND/OR THERAPY OF ENDOMETRIOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/464940
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2103
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227564.pdf
[firstpage_image] =>[orig_patent_app_number] => 12464940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/464940 | DRUG FOR PREVENTION AND/OR THERAPY OF ENDOMETRIOSIS | May 12, 2009 | Abandoned |
Array
(
[id] => 6113518
[patent_doc_number] => 20110190309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/992226
[patent_app_country] => US
[patent_app_date] => 2009-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27550
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190309.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992226
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992226 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST | May 11, 2009 | Abandoned |